Keyword Connections

major depressive disorder

Journals

21

1 progress in neuro-psychopharmacology & biological psychiatry

2 Frontiers in psychiatry

3 Behavioural brain research

4 planta medica

5 Journal of affective disorders

6 Life (Basel, Switzerland)

7 zhonghua yi xue za zhi

8 Journal of nanoscience and nanotechnology

9 Neuropsychiatric disease and treatment

10 Appetite

11 neuroimage clinical

12 clinical neurophysiology : official journal of the international federation of clinical neurophysiology

13 BMC psychiatry

14 pharmacology, biochemistry, and behavior

15 Nursing for women's health

16 australian and new zealand journal of public health

17 brain research bulletin

18 bone marrow transplantation

19 brain stimulation

20 the world journal of biological psychiatry : the official journal of the world federation of societies of biological psychiatry

21 alternative medicine review : a journal of clinical therapeutic

Research Groups

0

No Research Group Connected

Bibliographies

31

1 Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review.

2 The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis.

3 Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.

4 Using text mining to extract depressive symptoms and to validate the diagnosis of major depressive disorder from electronic health records.

5 Altered dynamic functional connectivity in weakly-connected state in major depressive disorder.

6 High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide.

7 C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.

8 Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.

9 Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.

10 Anhedonic-like behavior correlates with IFNγ serum levels in a two-hit model of depression.

11 Overeating and food addiction in Major Depressive Disorder: Links to peripheral dopamine.

12 A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depression.

13 [A pilot study of transcranial alternating current stimulation in the treatment of drug-naive adult patients with major depressive disorder].

14 Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity.

15 Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study.

16 Harmful drinking is associated with mental health conditions and other risk behaviours in Australian young people.

17 Subtypes of Depression: Latent Class Analysis in Spanish Old People with Depressive Symptoms.

18 neuroinflammation and behaviour

19 brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses

20 depressive-like behavioural profiles in captive-bred single- and socially-housed rhesus and cynomolgus macaques: a species comparison

21 symptom severity, affective and somatic symptom clusters predict poorer social cognition performance in current but not remitted major depressive disorder

22 t cell phenotype and t cell receptor repertoire in patients with major depressive disorder

23 subjective mood in young unmedicated depressed women under high and low sleep pressure conditions

24 determining the role of gender in relation between sexual desire and quality of life in patients with major depression

25 a review of the role of social cognition in major depressive disorder

26 changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset

27 exercise leads to better clinical outcomes in those receiving medication plus cognitive behavioral therapy for major depressive disorder

28 neural activity during interoceptive awareness and its associations with alexithymia – an fmri study in major depressive disorder and non-psychiatric controls

29 pattern separation: a potential marker of impaired hippocampal adult neurogenesis in major depressive disorder

30 Prediction of Probable Major Depressive Disorder in the Taiwan Biobank: An Integrated Machine Learning and Genome-Wide Analysis Approach

31 Plasma alpha-trypsin inhibitor heavy chain 4 as an age-specific biomarker in the diagnosis and treatment of major depressive disorder.